During the past decade, City Hospital #26 conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 9 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 7 clinical trials were completed. i.e. 700% of trials that started reached the finish line.

Out of the total clinical trials conducted in "City Hospital #26" #1 sponsor was "Celgene" with 5 trials, followed by "Ferring Pharmaceuticals" with 4 trials sponsored, "Galapagos NV" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "POLYSAN Scientific & Technological Pharmaceutical Company" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "City Hospital #26" #1 collaborator was "Gilead Sciences" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "OCT Clinical Trials" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "City Hospital #26" are "Prostate Cancer" (4 trials), "Ulcerative Colitis" (4 trials), "Crohn Disease" (2 trials), "Rheumatoid Arthritis" (2 trials) and "Acute Stroke" (1 trials). Many other conditions were trialed in "City Hospital #26" in a lesser frequency.

Most popular intervention types in "City Hospital #26" are "Drug" (20 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Degarelix" (3 trials), "GED-0301" (3 trials), "Adalimumab" (2 trials) and "Etrolizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "City Hospital #26" are 16 trials for "All" genders, 4 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "City Hospital #26". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in City Hospital #26, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in City Hospital #26, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".